MEDDDICAL Launches Real-World Evidence Strategy & Analytics For Pharma & MedTech [TheStreet.com]
IQVIA Holdings, Inc. (IQV)
Last iqvia holdings, inc. earnings: 4/28 07:00 am
Check Earnings Report
US:NYSE Investor Relations:
ir.iqvia.com
Company Research
Source: TheStreet.com
guidance to pharmaceutical and MedTech companies at a time when real-world evidence requirements from regulators and payers are growing more demanding across global drug development programs. More information is available at https://medddical.com/ According to a 2024 IQVIA report , the volume of available real-world health data has grown considerably, yet many pharmaceutical organizations still face challenges in turning that data into evidence that can stand up to regulatory or payer scrutiny. The central issue is rarely a lack of data; more often, it is the difficulty of determining which sources, analytical frameworks, and compliance structures fit a program's requirements before significant resources are committed. That is the gap MEDDDICAL aims to address. The team provides independent advisory support across insurance claims data strategy, synthetic patient cohort design, AI-powered analytics guidance, and market access strategy consulting. Operating outside the vendor eco
Show less
Read more
Impact Snapshot
Event Time:
IQV
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
IQV alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
IQV alerts
High impacting IQVIA Holdings, Inc. news events
Weekly update
A roundup of the hottest topics
IQV
News
- Lilly weight loss pill prescriptions said to near 1,400 in first week of launch [Seeking Alpha]Seeking Alpha
- IQVIA.ai Launch With NVIDIA Puts IQVIA's AI Valuation In Focus [Yahoo! Finance]Yahoo! Finance
- IQVIA to Announce First-Quarter 2026 Results on May 5, 2026Business Wire
- IQVIA (IQV) had its "outperform" rating reaffirmed by Evercore Inc.MarketBeat
- UPSHER-SMITH LAUNCHES GENERIC VERSION OF CIPRODEX® (CIPROFLOXACIN 0.3% AND DEXAMETHASONE 0.1%) STERILE OTIC SUSPENSION [TheStreet.com]TheStreet.com
IQV
Earnings
- 2/5/26 - Beat
IQV
Sec Filings
- 3/27/26 - Form SCHEDULE
- 2/27/26 - Form ARS
- 2/27/26 - Form DEFA14A
- IQV's page on the SEC website